Observational studyArthritis research & therapy2022

Rheumatoid arthritis patients initiating rituximab with low number of previous bDMARDs failures may effectively reduce rituximab dose and experience fewer serious adverse events than patients on full dose: a 5-year cohort study.

Antonios Bertsias et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.